Science

NOSTER is promoting the formation of strong and long term global partnerships to establish a new therapeutic foundation targeting the gut microbiome. The aim is to share the results of clinical trials conducted in Japan with research institutions and pharmaceutical companies around the world to accelerate drug development. In addition, NOSTER’s lipid metabolite library contains several compounds as potential candidates for therapeutic drugs for not only chronic diseases but also immune system and neurological diseases, and we are aiming to further expand drug the discovery pipeline thought global alliances.

University, research institute Researcher Research theme

University, research institute

Graduate School of Agriculture, Kyoto University

Researcher

Jun Ogawa
Shigenobu Kishino

Research theme

Search and practical applications of gut microbe lipid metabolites

University, research institute

Graduate School of Biostudies, Kyoto University

Researcher

Ikuo Kimura

Research theme

Explorations of functionality of beneficial gut microbes and their metabolites

University, research institute

Graduate Department of Gynecology and Obstetrics, School of Medicine, Kyoto University

Researcher

Eiji Kondo

Research theme

Correlation between brain dysfunction of premature babies and their mothers’ microbiome

University, research institute

National Institutes of Biomedical Innovation, Health and Nutrition

Researcher

Jun Kunisawa

Research theme

Analysis of the gut microbiome

University, research institute

Keio University School of Medicine

Researcher

Hiroshi Itoh

Research theme

Clinical applications of gut-microbial metabolites

University, research institute

Keio University Faculty of Pharmacy / RIKEN Center for Integrative Medical Sciences

Researcher

Makoto Arita

Research theme

Beneficial microorganisms and elucidating biokinetics of their metabolites and metabolisms

University, research institute

Kobe University Graduate School of Medicine

Researcher

Tomoya Yamashita

Research theme

Clinical applications for beneficial microorganisms

University, research institute

Kobe University Graduate School of Medicine

Researcher

Wataru Ogawa

Research theme

Clinical applications of gut- microbial lipid metabolites

University, research institute

Institute for Quantitative Biosciences, The University of Tokyo

Researcher

Reiko Shinkura

Research theme

Effect of microorganisms and their metabolites on immune system

Featured

2020.11.02

Gut microbes

More than 1,000 species including over 100 trillion gut microbes coexist and form varieties of microorganism-ecosystems …

Read More

2020.11.02

Cultivation technology

Gut microbes form symbiotic relationships and form stable communities in the oxygen free environment of the human gut. I…

Read More

2020.11.02

Bacteroides

Bacteroides vulgatus and B. dorei are predominant and anaerobic rod-shaped bacteria that are isolated from the human int…

Read More

2020.11.02

HYA (10-hydroxy-cis-12-octadecenoic acid): Gut microbial lipid metabolite

Currently, diabetes is treated with drugs that control blood sugar levels, but it not these drugs that treats diabetes i…

Read More

  • MRX MicrobiomeResearch X
  • NOSTER | Science Microbiome Prize